medigraphic.com
ISSN 2594-1526 (Digital)
ISSN 0028-3746 (Impreso)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2007, Número 4

<< Anterior Siguiente >>

Neumol Cir Torax 2007; 66 (4)


Patologías obstructivas de la vía aérea: Crisis asmática

Contreras ZE, Zuluaga MSX, Casa QIC, Plaza RB

Idioma: Español
Referencias bibliográficas: 66
Paginas: 161-173
Archivo PDF: 304.85 Kb.


RESUMEN

El asma es una enfermedad crónica que se caracteriza por ataques recurrentes de disnea y sibilancias, que varían en severidad y frecuencia de una persona a otra. Los síntomas pueden sobrevenir varias veces al día o a la semana, y en algunas personas se agravan durante la actividad física o por la noche. Los síntomas recurrentes causan con frecuencia insomnio, fatiga diurna, una disminución de la actividad y absentismo escolar y laboral. La tasa de letalidad del asma es relativamente baja en comparación con otras enfermedades crónicas; no obstante, en 2005 fallecieron 255,000 personas por esa causa.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Levi ML. International Primary Care Respiratory Group (IPCRG) Guidelines: diagnosis of respiratory diseases in primary care. Prim Care Respir J 2006; 15(1): 20-34.

  2. Siddiki AA. The incidence of adult asthma: a review. Int J Tuberc Lung Dis 2005; 9(6): 603-12.

  3. Castillo G. Crisis asmática. En: Guías de Atención Prehospitalaria. Ministerio de Protección Social. 2005.

  4. Asociación Colombiana de Neumología y Cirugía de Tórax. Comité Nacional Conjunto de Asma. ASMA. Guías para diagnóstico y manejo. Rev Colomb Neumol 2003; 15 (Supl 2): S1-S90.

  5. Apter J. Advances in adult asthma 2006: its risk factors, course, and management. J Allergy Clin Immunol 2007; 119(3): 563-6.

  6. Ellis K. Asthma pathogenesis and management. Nurse Pract 2006; 31(11): 24-37.

  7. Holgate ST. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006; 368(9537): 780-93.

  8. Larche M. Regulatory T cells in allergy and asthma. Chest 2007; 132(3): 1007-14.

  9. Finkelman F. Advances in asthma, allergy mechanisms, and genetics in 2006. J Allergy Clin Immunol 2007; 120(3): 544-50.

  10. Ducharme FM, Hicks GC. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  11. Pelaia G. Respiratory infections and asthma. Respir Med 2006; 100(5): 775-84.

  12. Morjaria JB. Anti-IgE in allergic asthma and rhinitis: an update. Expert Opin Biol Ther 2007; 7(11): 1739-47.

  13. Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med 2006; 6 Suppl 1: S4.

  14. Mills T. The role of allergens in asthma. Am Fam Physician 2007; 76(5): 675-80.

  15. Palma AG. The asthma rhinitis link. Allerg Immunol (Paris) 2007; 39(6): 195-9.

  16. Von E. Asthma and allergies in rural areas of Europe. Proc Am Thorac Soc 2007; 4(3): 212-6.

  17. Grupo de Trabajo Respiratorio de la SAMFYC. Guía de Práctica Clínica de Asma. Sociedad Andaluza de Medicina Familiar y Comunitaria 26/2/2002.

  18. Tapps S. Education interventions for adults who attend the emergency room for acute asthma. Cochrane Database Syst Rev 2007; (3): CD003000.

  19. Irani AM. The challenge of mild persistent asthma. Ann Allergy Asthma Immunol 2005; 94(5): 517-27.

  20. National Institutes of Health (NIH). National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. NIH; 2004.

  21. Rodrigo GJ, Rodrigo C, Hall JB. Acute Asthma in adults: a review. Chest 2004; 125: 1081–1102.

  22. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. In: The Cochrane Library, Issue 2, 2004 Chichester, UK: John Wiley & Sons, Ltd.

  23. Slaughter MC. Not quite asthma: differential diagnosis of dyspnea, cough, and wheezing. Allergy Asthma Proc 2007; 28(3): 271-81.

  24. Moore WC. Severe asthma: an overview. J Allergy Clin Immunol 2006; 117(3): 487-94.

  25. Apter AJ. Advances in adult and pediatric asthma. J Allergy Clin Immunol 2006; 117(3): 512-8.

  26. Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma. British Thoracic Society; 2004.

  27. Lopez A. Guidelines for the diagnosis and management of difficult-to-control asthma Arch Bronconeumol 2005; 41(9): 513-23.

  28. ICSI Health Care Guideline. Diagnosis and management of asthma. ICSI; 2003.

  29. Bush A. The challenge of asthma in adolescence. Pediatr Pulmonol 2007; 42(8): 683-92.

  30. Price D. Breaking new ground: challenging existing asthma guidelines. BMC Pulm Med 2006; 6 Suppl 1: S6.

  31. Holgate S. Asthma out of control? A structured review of recent patient surveys. BMC Pulm Med 2006; 6 Suppl 1: S2.

  32. Dennis R. Asthma. Clin Evid 2005; (14): 1847-77.

  33. Navarro RP. Asthma treatment guidelines: how do we measure up? Am J Manag Care 2005; 11(14 Suppl): S422-6.

  34. Rees J. Asthma control in adults. BMJ 2006; 332(7544): 767-71.

  35. Travers AH, Rowe BH, Barker S, et al. The effectiveness of IV b-Agonists in treating patients with acute asthma in the emergency department: A meta-analysis. Chest 2002; 122: 1200–1207.

  36. Shih Y. A cost-effectiveness analysis of first-line controller therapies for persistent asthma. Pharmacoeconomics 2007; 25(7): 577-90.

  37. Rodrigo GJ, Rodrigo C. Continuous vs intermittent b-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 2002; 122: 160–165.

  38. Cannon E. Aligning patient care and asthma treatment guidelines. Am J Manag Care 2005; 11(14 Suppl): S416-21.

  39. Corren J. Evaluation and treatment of asthma: an overview. Am J Manag Care 2005; 11(14 Suppl): S408-15.

  40. Becker A. Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ 2005; 173(6 Suppl): S3-11.

  41. Emond S. Addition of intravenous aminophylline to b2-agonist in adults with acute asthma. Ann Emerg Med 2002; 40: 350–352.

  42. Rodrigo G, Rodrigo C, Burschtin O. Ipratropium bromide in acute adult severe asthma: a meta-analysis of randomized controlled trials. Am J Med 1999; 107: 363-370.

  43. Rodrigo GJ, Rodrigo C. The Role of Anticholinergics in acute asthma treatment: An evidence-based evaluation. Chest 2002; 121: 1977–1987.

  44. Restrepo R. Use of inhaled anticholinergic agents in obstructive airway disease. Respir Care 2007; 52(7): 833-51.

  45. Barnes PJ. Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control. BMJ 2007; 335(7618): 513.

  46. Harrinson BD. Difficult asthma in adults: recognition and approaches to management. Intern Med J 2005; 35(9): 543-7.

  47. Weiss K. Clinical assessment of asthma symptom control: review of current assessment instruments. J Asthma 2006; 43(7): 481-7.

  48. Makino S. Pharmacologic control of asthma. Int Arch Allergy Immunol 2005; 136 Suppl 1: 14-49.

  49. Allayee H. The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. Chest 2007; 132(3): 868-74.

  50. Strom W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother 2007; 8(13): 2173-87.

  51. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  52. Blits M. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2005; (3): CD003898.

  53. Silverman RA, Osborn H, Bunge J, et al. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest 2002; 122: 489–497.

  54. Bernard A. Management of an acute asthma attack. Aust Fam Physician 2005; 34(7): 531-4.

  55. Hondras MA. Manual therapy for asthma. Cochrane Database Syst Rev 2005; (2): CD001002.

  56. Rodrigo G. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006; (4): CD002884.

  57. Kim I. Heliox-driven albuterol nebulization for asthma exacerbations: an overview. Respir Care 2006; 51(6): 613.

  58. Brenan J. Noninvasive ventilation for critical care. Chest 2007; 132(2): 711-20.

  59. Ram FS. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005; (3): CD004360.

  60. Higgins BS. Permissive hypercapnia: role in protective lung ventilatory strategies. Curr Opin Crit Care 2005; 11(1): 56-62.

  61. Cook DH. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med 2004; 32(12): 2516-23.

  62. Tobias JD. Non-invasive ventilation using bilevel positive airway pressure to treat impending respiratory failure in the post anaesthesia care unit. J Clin Anesth 2000; 12: 409-12.

  63. Peigang Y, Marini JJ. Ventilation of patients with asthma and chronic obstructive pulmonary disease. Curr Opin Crit Care 2002; 8(1): 70-6.

  64. Rodrigo C. Severe acute asthma: its management in emergency visits and intensive care. Med Intensiva 2006; 30(9): 460-70.

  65. Pierson DJ. Indications for mechanical ventilation in adults with acute respiratory failure. Respir Care 2002; 47(3): 249-62.

  66. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med 2001; 163: 540-77.




2020     |     www.medigraphic.com